Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Shiwei Capsule (FuFang ShiWei Jiao Nang) is a traditional Chinese herbal medicine (TCM) formulation primarily used for the treatment of urinary tract and renal conditions. It is composed of several herbal ingredients, including *Pyrrosia* (Shiwei), *Astragalus* (Huangqi), *Sophora flavescens* (Kushen), and *Polygonum aviculare* (Bianxu). The formulation is traditionally indicated for clearing heat and dampness and promoting diuresis. Clinically, it is used to alleviate symptoms such as frequent, urgent, or painful urination and lower limb edema, and is applied in the management of acute and chronic glomerulonephritis, pyelonephritis, cystitis, and urethritis. It is distributed by Shuangren Pharmaceutical, which is part of the Lonch Group (Langzhi Group).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Compound Shiwei Capsule.